Clinical trial
Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
NCT00127036 · H. Lee Moffitt Cancer Center and Research Institute, Other · Terminated
Key facts
| NCT number | NCT00127036 |
|---|---|
| Title | Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) |
| Official title | A Multicenter Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) |
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adenocarcinoma, Colon Cancer |
| Intervention type | Drug |
| Interventions | XELOX, XELIRI, Bevacizumab |
| Enrollment | 65 |
| Start date | Oct 1, 2003 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Aug 5, 2005 |
| Last update posted | Mar 23, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: